Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Citric Acid | HCID 311 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | 4-Chloro-1-(2-chlorophenyl)-1H-pyrazolo[3,4-D]pyrimidine | HCID 11265570 | — |
| Reactant | (S)-2-hydroxy-N-(pyridin-2-yl)-3-((R)-1-(triisopropylsilyloxy)propan-2-yloxy)propanamide | HCID 57504690 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 57504547 | HCID 57504547 | 59.4% |
Reaction Steps
Sodium hydride (78 mg, 1.95 mmol) was added to (S)-2-hydroxy-N-(pyridin-2-yl)-3-((R)-1-(triisopropylsilyloxy)propan-2-yloxy)propanamide (Intermediate AQ4) (387 mg, 0.98 mmol) in anhydrous THF (20 mL). The resulting solution was stirred at 0° C. for 10 minutes and then 4-chloro-1-(2-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidine (Intermediate B1) (250 mg, 0.89 mmol) was added. The reaction mixture was allowed to warm to room temperature and stirred for 1 hour. The reaction mixture was neutralised with 1M citric acid and the majority of the THF removed in vacuo. The reaction mixture was diluted with water (20 mL) and EtOAc (50 mL). The organic layer was separated and the aqueous layer re-extracted with EtOAc (2×100 mL). The combined organics were washed with saturated brine (75 mL), dried (MgSO4) and evaporated. The crude product was purified by flash silica chromatography, eluting with 50 to 100% EtOAc in isohexane to afford the product (329 mg, 59.4%). 1H NMR (400 MHz, CDCl3) δ 1.01-1.15 (24H, m), 3.55-3.78 (3H, m), 4.19-4.35 (2H, m), 6.03 (1H, t), 7.05 (1H, t) 7.40-7.65 (4H, m), 7.7 (1H, t), 8.2-8.3 (2H, m), 8.43 (1H, s), 8.58 (1H, s), 8.75 (1H, s); m/z (ES+) M+=625.44; HPLC tR=4.02 min.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08143263B2 |
|---|
| Source dataset | uspto-grants-2012_03 |
|---|
| ORD ID | ord-51d6832fa18141c78097935e03aaf39c |
|---|
| Source note | uspto-grants-2012_03 |
|---|